Destiny Pharma Share Price (DEST)

Share Name Share Symbol Market Type Share ISIN Share Description
Destiny Pharma Plc LSE:DEST London Ordinary Share GB00BDHSP575 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 36.50 1,000 08:00:00
Bid Price Offer Price High Price Low Price Open Price
36.00 37.00 36.50 36.50 36.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -6.01 -11.90 16
Last Trade Time Trade Type Trade Size Trade Price Currency
08:23:18 O 1,000 36.00 GBX
Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Motif Bio (MTFB), Geiger Counter (GCS)

Destiny Pharma (DEST) Latest News

Destiny Pharma News

Date Time Source Headline
20/1/202011:44ALNCDestiny Pharma Completes First Phase Of Collaboration With MedPharm
20/1/202007:26ALNCFAlliance News Flash Headline
20/1/202007:00RNSNONDestiny Pharma PLC Update on the development of XF drug formulations
17/12/201916:06ALNCDestiny Pharma Says New Guidelines Prove Lead Product Marketability
17/12/201907:00RNSNONDestiny Pharma PLC APSIC guidelines recommend decolonising S. aureus
02/12/201915:57ALNCDestiny Pharma Appoints Former Polyphor Medical Chief To Board
02/12/201907:01UKREGDestiny Pharma PLC Directorate Change
02/12/201907:00UKREGDestiny Pharma PLC Destiny to present at UK-China AMR Workshop
15/11/201907:30RNSNONDestiny Pharma PLC Presentation at the Investival Showcase
06/11/201907:00RNSNONDestiny Pharma PLC Destiny Pharma to present at World AMR Congress
More Destiny Pharma News
Destiny Pharma Takeover Rumours

Destiny Pharma (DEST) Discussions and Chat

Destiny Pharma Forums and Chat

Date Time Title Posts
20/1/202007:30Destiny Pharma plc59

Add a New Thread

Destiny Pharma (DEST) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
08:23:1936.001,000360.00O
View all Destiny Pharma trades in real-time

Destiny Pharma (DEST) Top Chat Posts

DateSubject
24/2/2020
08:20		Destiny Pharma Daily Update: Destiny Pharma Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker DEST. The last closing price for Destiny Pharma was 36.50p.
Destiny Pharma Plc has a 4 week average price of 36p and a 12 week average price of 36p.
The 1 year high share price is 85.50p while the 1 year low share price is currently 34.50p.
There are currently 43,815,195 shares in issue and the average daily traded volume is 6,909 shares. The market capitalisation of Destiny Pharma Plc is £15,992,546.18.
Read Full Thread
Reply
14/8/2019
10:24		johnniew156: Literally a couple of minutes after my posting, B'berg popped up with a delayed trade on the QR page. 1.4m shares were crossed at 35p at 15:56.18 yesterday, so yesterday's volume has been adjusted to 1,438,389 shares. In my view it would be extremely coinciental if this sale (of 1.4m shares) was not the balance of the 1.521943m Garraway stake that I am guessing was placed directly into market at least initially & ended up smashing the share price yesterday.
Read Full Thread
Follow
Reply
14/8/2019
07:31		aspringo: Just my tuppence worth on this share.I'm foolishly topping up and 3 of the purchase made today are mine tjough showing as sales.As far as i can see the story hasnt changed. So far delivered exactly as promised but now the share price is at a fraction of the IPO.Someone may know whats going on, but until then I'll take a chance and keep accumalating.Apologies for my naivety. Good luck all
Read Full Thread
Follow
Reply
05/10/2018
10:54		edmonda: new analysis on pipeline's development and expansion, with increased fair value as a result (a multiple of current share price). Plenty of news expected in coming weeks, too. Note freely accessible here: https://www.equitydevelopment.co.uk/edreader/?ltkn=5f3dec7ebec4cbdaf80bd7d872a074b0AvbosF0F&d=%3D%3DAO4QjM
Read Full Thread
Follow
Reply
02/10/2017
13:47		jonwig: At the risk of being a boor, I'll repeat my post #7 from four weeks ago: I saw the initial RNS and looked at the website. Basically their compounds appear to act so quickly that bacteria have no time to develop resistance via mutation. My immediate reaction to this was extreme scepticism. It appears to suggest that antibiotic resistant mutations happen when bacteria are stimulated by exposure to an agent. But this isn't the case: they happen purely randomly. Indeed there will already exist resistant strains, and resistant populations will develop and increase by natural selection as happens with current antibiotics. I met a biochemist last week (on holiday) whose discipline is immunology, so not quite the same, and he confirmed that my general understanding was correct. Obviously I need to do more study on this and it would be good to see if the company's research has been peer-reviewed. (A lot of these companies don't allow that.) I know their early trials have been successful, and I may be off-beam here, but I wouldn't want to invest in anything I didn't understand. I just can't find any corroborative information about their compounds (Help anyone?), and first results should be some time away. (How much?) Until then, it's unlikely the share price will do more than respond to speculative froth. A trigger will be phase results, and it's unlikely these can leak as they should be double-blind and reported immediately. When they are, how many here will understand them? More to the point, they seem to have £14m cash with a burn of £2m pa (but that will increase). At least they won't have to scramble.
Read Full Thread
Follow
Reply
Destiny Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
DEST
Destiny Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200224 12:34:57